Novo Nordisk Vs. Eli Lilly: Judged Against Big Pharma, Only One Needs A Premium (NYSE:NVO)
· seekingalpha.com
Novo Nordisk trades at ~11.2x 2027 earnings, a ~26% discount to peer median. Read more on why NVO stock is a Buy and LLY stock is a Hold.
The Novo Nordisk ( NVO ) ( NONOF ) versus Eli Lilly ( LLY ) story does not have a counterintuitive twist. I try to keep the analysis focused on numbers, in an a...